Patients
in sentence
2016 examples of Patients in a sentence
For
patients
who have not responded to conventional treatment, restoring function should replace eradicating pain as the primary objective.
Similarly,
patients
must recognize that there are no “silver bullets” for pain treatment.
Indiscriminate use of procedures that may benefit only a select few
patients
merely drives up health-care costs.
Finally, researchers should compare the long-term cost-effectiveness of different treatments in typical chronic-pain
patients.
Indeed, without better evidence, efforts to help
patients
may well end up creating more problems than they solve.
In many such patients, doubling the dose of Plavix, and checking the platelet function with a point-of-care test to assure suppression, can override the lack of response.
The story of interferon, given for one year to
patients
with hepatitis C virus, is particularly striking.
This treatment is very costly (about $50,000) and makes all
patients
feel quite ill with flu-like symptoms and general malaise.
Moreover, most health IT systems in use in America today are designed primarily to facilitate efficient billing, rather than efficient care, putting the business interests of hospitals and clinics ahead of the needs of doctors and
patients.
Developers can boost the pace of adoption by creating more standardized systems that are easier to use, truly interoperable, and afford
patients
greater access to and control over their personal health data.
Such a pilot program would benefit poor
patients
and would test scientists’ ability to measure health impact fairly and accurately.
After recovering from VL, many
patients
in Bangladesh go on to develop a condition known as macular post-kala-azar dermal leishmaniasis.
In order to find out whether PKDL
patients
can act as a reservoir for VL – and therefore boost our capacity to eradicate the disease – my team and I have set up an insectarium to breed sterile sandflies.
But, because antibodies persist in the blood even after recovery, this method falsely identifies healthy, non-contagious
patients
as needing treatment.
A Mexican survey shows that in private care, poor
patients
(particularly indigenous women) receive worse care than the wealthy, although there is little difference in public institutions.
The new wave of innovation is attributable to three key factors: the ability to personalize therapy, the capacity to get treatments to market faster, and improved engagement with
patients.
Genetic markers, for example, can indicate which
patients
are likely to benefit from a drug, thereby improving outcomes while allowing
patients
to avoid potentially painful side effects of treatments that are unlikely to work.
For early-stage breast cancer patients, genetic markers show whether chemotherapy is likely to have an impact, or if hormone therapy alone is the better option.
A new lung cancer drug developed by my company, Novartis, is effective only in
patients
with non-small-cell lung cancer who have a particular genetic mutation.
For example, diabetes
patients
in the United States with the lowest level of compliance have a 30% yearly risk of hospitalization, compared to a 13% risk for
patients
with a high level of adherence.
Technologies that engage
patients
in their own health care and enable more seamless adherence to medication regimes have the potential to improve disease management, reduce hospitalization, and lower costs.
For
patients
and providers alike, this is very good news.
The program’s effectiveness will be evaluated by a randomized control trial comparing the data of
patients
who participated with those who did not.
Observational studies that compare outcomes for
patients
who receive particular treatments and control subject who do not rank higher, but may still be misleading.
Convincing studies of drugs and surgical procedures usually come only from randomized trials, in which
patients
receive treatment or don’t according to a process analogous to a coin flip.
Well-conducted randomized trials incorporate additional safeguards against bias, including use of placebo medication that allows investigators to blind
patients
and caregivers to whether
patients
are, or are not, receiving active treatment.
Similarly, cardiologists once prescribed drugs to reduce sudden death in
patients
after heart attacks.
Unfortunately, when investigators undertook randomized trials, they found that treated
patients
had a higher death rate.
The result is cutting corners, deficiencies in care, and poorer outcomes for
patients.
Displaced doctors are better able to treat refugee patients’ ailments.
Back
Next
Related words
Their
Doctors
Health
About
Treatment
Which
Would
Other
Medical
There
Cancer
People
Could
Hospital
Disease
Drugs
After
Where
Often
Years